Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:12 PM
Ignite Modification Date:
2025-12-24 @ 4:12 PM
NCT ID:
NCT00985166
Eligibility Criteria:
Inclusion Criteria:
* In good health
* Received primary dose of M-M-R II at less than or equal to 12 months of age
* Received primary dose of Varivax at less than or equal to 12 months of age
* Negative history of varicella, zoster, measles, mumps, and rubella
Exclusion Criteria:
* history of receiving more than once dose of M-M-R II or Varivax
* Any immune impairment or deficiency
* Exposure to measles, mumps, rubella, varicella, or zoster in the 4 weeks prior to vaccination
* Vaccination with an inactive vaccine with in the past 14 days
* Vaccination with a live vaccine within the past 30 days
* Receipt of immune globulin, or blood product in the past 5 months
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
6 Years
Study:
NCT00985166
Study Brief:
Protocol Section:
NCT00985166